<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新浪医药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-17T16:49:06+08:00</updated>
  <subtitle>新浪医药新闻为医药行业从业者提供新鲜全面的医药资讯、权威的医药政策专家解读、药企药店医院新药新闻资讯动态，以及畅所欲言的专栏平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2021年基因治疗领域面临的5个重要问题！</title>
    <updated>2021-01-17T16:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/wcxSvZQCXKokgOR3snzN7g</id>
    <link href="https://mp.weixin.qq.com/s/wcxSvZQCXKokgOR3snzN7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品内标签的意义，岂能只是合规？</title>
    <updated>2021-01-17T16:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/-Zw-C4bJcNNnU9PyxRfb3Q</id>
    <link href="https://mp.weixin.qq.com/s/-Zw-C4bJcNNnU9PyxRfb3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨“大头娃娃”事件通报：涉事产品含激素；某药企员工感染新冠</title>
    <updated>2021-01-17T16:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/2VQjXjz-BCYugQZrrkxmcA</id>
    <link href="https://mp.weixin.qq.com/s/2VQjXjz-BCYugQZrrkxmcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周药闻丨布罗舒单抗在华获批上市 百济神州PD-1肺鳞癌适应症获批</title>
    <updated>2021-01-15T23:59:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/m3MGg9F8pehSvIUUjVei6w</id>
    <link href="https://mp.weixin.qq.com/s/m3MGg9F8pehSvIUUjVei6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采2月3日开标！45个品种，涉及百家药企（附目录）</title>
    <updated>2021-01-15T23:59:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/rA5htJFFeOlLUNLGNK8zpw</id>
    <link href="https://mp.weixin.qq.com/s/rA5htJFFeOlLUNLGNK8zpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点2002-2020年获批上市的11个EGFR抑制剂</title>
    <updated>2021-01-15T17:20:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/0Zjgtvt9BpsjIBhkcEhi8w</id>
    <link href="https://mp.weixin.qq.com/s/0Zjgtvt9BpsjIBhkcEhi8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东前研发执行官涉嫌盗取公司大量研究数据</title>
    <updated>2021-01-15T17:20:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/yWqfztIQVDGdL3ymCaXZYQ</id>
    <link href="https://mp.weixin.qq.com/s/yWqfztIQVDGdL3ymCaXZYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨复宏汉霖获得TROP2抗体新药中国区独家权利 贝达药业1类新药BET抑制剂获批临床</title>
    <updated>2021-01-15T17:20:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/jEU9hFhOLEJDBL6A-v2A7w</id>
    <link href="https://mp.weixin.qq.com/s/jEU9hFhOLEJDBL6A-v2A7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“中国首富”钟睒睒辞职！“厦大系“接管万泰生物，卖水人的医药“下一城”</title>
    <updated>2021-01-14T18:00:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/6x6u7YOpzPo4SyuZ5FRvpQ</id>
    <link href="https://mp.weixin.qq.com/s/6x6u7YOpzPo4SyuZ5FRvpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来、豪森长效GLP-1医保价流出！国采后原研落选药品也降价了</title>
    <updated>2021-01-14T18:00:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/7OZay29ePm8Ulnc75Gj3qQ</id>
    <link href="https://mp.weixin.qq.com/s/7OZay29ePm8Ulnc75Gj3qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨酚酞片、酚酞含片全面停产禁售 李智明辞任现代制药副董事长等职务</title>
    <updated>2021-01-14T18:00:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/1P6yUB8o68VXiJgqeGrMVA</id>
    <link href="https://mp.weixin.qq.com/s/1P6yUB8o68VXiJgqeGrMVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年上半年值得关注的关键临床试验</title>
    <updated>2021-01-13T18:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/UubvJ_XFdrQPMasc6w65Lw</id>
    <link href="https://mp.weixin.qq.com/s/UubvJ_XFdrQPMasc6w65Lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>央视报道“用体温融化结冰的核酸检测试管”，这结果还能准确吗？</title>
    <updated>2021-01-13T18:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/K5C2Z_z_skJP5mMPw3t8DQ</id>
    <link href="https://mp.weixin.qq.com/s/K5C2Z_z_skJP5mMPw3t8DQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全棉时代自夸式道歉被怒嘲，医药行业还有哪些危机公关值得关注？</title>
    <updated>2021-01-13T18:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/vNm949vW4x45R4p5uSWm1g</id>
    <link href="https://mp.weixin.qq.com/s/vNm949vW4x45R4p5uSWm1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨百济PD-1第三个适应症获批上市 默沙东15价肺炎疫苗获FDA优先审查资格</title>
    <updated>2021-01-13T18:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/iVyk1hS4DQ74BgBW2l7oXw</id>
    <link href="https://mp.weixin.qq.com/s/iVyk1hS4DQ74BgBW2l7oXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判后PD-1战火升级！“OK”大降价，达伯舒促销，百泽安出海</title>
    <updated>2021-01-12T17:40:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/qT7sucWp99SQXUiKT9HBYg</id>
    <link href="https://mp.weixin.qq.com/s/qT7sucWp99SQXUiKT9HBYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千亿赛道开启，谁将在互联网慢病管理产业中领跑？</title>
    <updated>2021-01-12T17:40:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/6-ghIBeWue3pxGAEfoZEMw</id>
    <link href="https://mp.weixin.qq.com/s/6-ghIBeWue3pxGAEfoZEMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨国内首款CAR-T：复星凯特阿基仑赛注射液即将获批 ​GSK与Eligo达成2.24亿美元合作</title>
    <updated>2021-01-12T17:40:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/c7X56HNEL9SmO6YWQhG6ow</id>
    <link href="https://mp.weixin.qq.com/s/c7X56HNEL9SmO6YWQhG6ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从“囚徒困境”走向“规范平衡“——探究2021药品集中采购新生态</title>
    <updated>2021-01-11T18:07:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/4ytEFvQFNv8GoldSdxYu_A</id>
    <link href="https://mp.weixin.qq.com/s/4ytEFvQFNv8GoldSdxYu_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年最值得关注的抗体药物</title>
    <updated>2021-01-11T18:07:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/3ITIyhRVv6Aeix-FMGV4tQ</id>
    <link href="https://mp.weixin.qq.com/s/3ITIyhRVv6Aeix-FMGV4tQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>